Central Institute of Mental Health in Mannheim

40 percent of all people have a mental illness in the course of their lives that should be treated.

We at CIMH are experts in mental health.

We study the causes and mechanisms of mental illnesses and develop new therapies.

We help with individual treatments and support prevention.

Successful application for German Center for Mental Health

The research alliance ZIHUb has qualified to design the new German Center for Mental Health together with other selected research sites from mid-2021.

The 3R Center supports research projects that obtain data using alternative approaches, such as cell systems and organoids. This should further reduce the number of animal experiments.

3R Center Rhine-Neckar: Strengthening animal welfare and improving methods

With the new 3R Center Rhine-Neckar, the commitment to animal welfare in research will be jointly promoted in the region in the future and the number...

Psilocybin depression study is starting

In a new study, a group of researchers led by Prof. Dr. Gerhard Gründer wants to gain robust findings on the efficacy and safety of psilocybin in the...

Researching the effects of new therapies

The Center for Innovative Psychiatric and Psychotherapeutic Research (CIPP) is a unique research platform to investigate the effects of new therapies on the brain, behavior and multiple biomarkers. Our goal is to gain fundamentally new insights into the mechanisms of neuropsychiatric diseases and to significantly accelerate the development of new drugs and psychotherapy procedures. Learn more.

The CIMH realigns itself

After the new building in K 3 and the modernization of the therapy building in J 5, another new building is currently under construction in J 4.

The CIMH 2020 Master Plan is a forward-looking approach to patient care and further improves the conditions for psychiatric research in Mannheim.

Ein Blick auf die Baustelle auf dem Campus am ZI in J 4 in Mannheim.

News about the new building

On the site in J 4, a new building is being constructed with direct access to our therapy building. We will keep you informed about the construction progress. You can find information about the construction site here.

Crisis / Emergency

7 am - 5 pm (only on weekdays)
+49 621 1703-2150

5 pm - 7 am and on weekends and public holidays
+49 621 1703-0

More information

Publications

Feld G, Bergmann TO, Alizadeh-Asfestani M, Stuke V, Wriede JP, Soekadar S, Born J. Specific changes in sleep oscillations after blocking human metabotropic glutamate receptor 5 in the absence of altered memory function. J Psychopharmacol. 2021 Apr 25. [Epub ahead of print] :2698811211005627.

Bach P, Weil G, Pompili E, Hoffmann S, Hermann D, Vollstädt-Klein S, Kiefer F, Mann KF, Sommer WH. FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study. Eur Arch Psychiatry Clin Neurosci. 2021 Apr 21. [Epub ahead of print]

Böttinger BW, Baumeister S, Millenet S, Barker GJ, Bokde AL, Büchel C, Quinlan EB, Desrivieres S, Flor H, Grigis A, Garavan H, Gowland P, Heinz A, Ittermann B, Martinot JL, Martinot MP, Artiges E, Orfanos DP, Paus T, Poustka L, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Banaschewski T, Brandeis D, Nees F, IMAGEN Consortium . Orbitofrontal control of conduct problems? Evidence from healthy adolescents processing negative facial affect. Eur Child Adolesc Psychiatry. 2021 Apr 16. [Epub ahead of print]

Georgiadou E, Koopmann A, MÜller A, Leménager T, Hillemacher T, Kiefer F. Who Was Shopping More During the Spring Lockdown 2020 in Germany?. Front Psychiatry. 2021 12:650989.

Karl D, Bumb JM, Bach P, Dinter C, Koopmann A, Hermann D, Mann KF, Kiefer F, Vollstädt-Klein S. Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder. Psychopharmacology (Berl). 2021 Apr 12. [Epub ahead of print]

Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de